New Mexico Moves to Expand Access to Opioid Use Disorder Treatment
New Mexico’s Health Care Authority (HCA) is proposing rule changes to align with updated federal regulations regarding medications for opioid use disorder (OUD). These changes, based on 42 CFR Part 8, aim to broaden treatment access, reduce stigma, and prioritize patient-centered care. A public hearing is scheduled for March 24, 2026, to gather feedback on the proposed amendments to 8.321.10 NMAC.
Federal Rule Updates Driving Change
The HCA’s action stems from revisions to 42 CFR Part 8, which took effect on April 2, 2024. These federal updates modernize standards for Opioid Treatment Programs (OTPs), focusing on evidence-based practices and patient needs. Key changes include updated terminology, eliminating unnecessary barriers to admission, and incorporating harm reduction principles into treatment plans.
What’s Changing in New Mexico?
The proposed rule changes in New Mexico reflect the federal updates. Specifically, the revisions aim to align state regulations with the expanded access to medication-assisted treatment (MAT) outlined in 42 CFR Part 8. This includes removing requirements like a one-year opioid addiction history for admission and allowing electronic consent for treatment. The changes as well emphasize shared decision-making between patients and providers.
How to Participate in the Public Hearing
The public hearing will be held virtually via Zoom on March 24, 2026, at 10:00 AM Mountain Time. Interested parties can join using the following details:
- Zoom Meeting Link: https://us02web.zoom.us/j/88098899503?pwd=84M0Y8n3yyFSLaxO2SHwAlHNLIaHLV.1
- Meeting ID: 880 9889 9503
- Passcode: 401112
- Phone Options: +17193594580 or +12532050468 (use Meeting ID and Passcode)
Individuals needing alternative formats or special accommodations to participate should contact the Behavioral Health Services Division at (505) 470-8378 at least ten working days in advance.
Submitting Written Comments
Written comments can be submitted via mail, email, or recorded message. The deadline for submissions is 5:00 p.m. MDT on March 24, 2026.
- Mailing Address: ATTN: Behavioral Health Services Division Public Comments, P.O. Box 2348, Santa Fe, New Mexico 87504-2348
- Recorded Comments: (505) 470-8378
- Email: [email protected]
All comments received will be posted on the HCA website at https://www.hca.nm.gov/behavioral-health-services-division-registers/ and hca.nm.gov/2026-comment-period-open/.
Looking Ahead: Trends in Opioid Use Disorder Treatment
The changes in New Mexico, driven by the federal updates to 42 CFR Part 8, reflect a broader shift in how opioid use disorder is treated. Several key trends are emerging:
Increased Access to Medication-Assisted Treatment
MAT, using medications like buprenorphine and methadone, is widely recognized as the most effective treatment for OUD. Removing barriers to access, as seen in the updated regulations, is crucial for expanding treatment reach.
Harm Reduction Strategies
The incorporation of harm reduction principles—such as naloxone distribution and syringe exchange programs—acknowledges that abstinence is not always the immediate goal. These strategies aim to reduce the negative consequences of drug use and maintain individuals alive.
Telehealth Expansion
While not explicitly mentioned in the provided documents, the increasing use of telehealth is transforming access to OUD treatment, particularly in rural areas. Telehealth allows patients to receive care remotely, overcoming geographical barriers.
Focus on Patient-Centered Care
The emphasis on shared decision-making between patients and providers reflects a growing recognition of the importance of individualized treatment plans. This approach empowers patients to take an active role in their recovery.
Frequently Asked Questions
Q: Where can I find the proposed rule changes?
A: The proposed changes are available on the HCA website at https://www.hca.nm.gov/behavioral-health-services-division-registers/ and https://www.hca.nm.gov/2026-comment-period-open/.
Q: What is 42 CFR Part 8?
A: It’s a federal regulation governing the standards for opioid treatment programs.
Q: What is the deadline for submitting comments?
A: Comments must be received by 5:00 p.m. MDT on March 24, 2026.
Q: Who should I contact if I need accommodations for the public hearing?
A: Contact the Behavioral Health Services Division at (505) 470-8378.
Stay informed about the latest developments in opioid use disorder treatment by visiting the SAMHSA website: https://www.samhsa.gov/.
